Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Global uncertainties can't dampen upbeat Jefferies conference
No matter who Fierce could pull aside for a quick coffee at the conference, the general view was of a renewed sense of cautious optimism.
James Waldron
Nov 24, 2025 3:00am
Expedition resupplies for ph. 2 COPD voyage with $165M series A
Oct 9, 2025 9:50am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
